Journal of Developing Drugs
Open Access

Sharafi H

Publications

• Research Article
  The Relationship of Polymorphism of RFC-I Gene on Methotrexate Serum Level and Related Toxicity in Pediatric Acute Lymphoblastic Leukemia
  Author(s): Zaker F, Ansari S, Toosi B, Sayadi M and Sharafi HZaker F, Ansari S, Toosi B, Sayadi M and Sharafi H
  
  Introduction: Methotrexate is one of the most effective agents in chemotherapy regimens for childhood ALL. However, methotrexate has remarkable side effects, which causes complications in various tissues and organs of some patients under treatment of this drug. It is proved that genetic factors can determine methotrexate toxicity. The aim of this study is to evaluate the effect of RFC-I A80G polymorphism on toxicity and serum level of methotrexate in children affected by acute lymphoblastic leukemia. Methods: A80G polymorphism of RFC-I was genotyped with PCR-RFLP method in 69 ALL patients treated with methotrexate. The relation between RFC-I genotypes and serum level of methotrexate and toxicity were evaluated using HPLC method and common terminology criteria for adverse events (CTCAE) respectively. Results: In this st.. View More»
  DOI: 10.4172/2329-6631.1000180

  Abstract PDF

Relevant Topics